— Avid Bioservices (NASDAQ: CDMO) reported a loss of $0.## per share for its third quarter of 2020 vs. expected loss of $0.04 per share.
— Revenue was $13.6 million vs. $15.42 million expected.
— As of January 31, 2020, revenue backlog was approximately $58 million.
— For fiscal 2020, the company reduced its revenue outlook to a range of $55 million to $59 million from the previously issued guidance of $64 million to $67 million.
— Avid Bioservices stated that the temporary production interruption resulted in lower revenue and profits for the third quarter. This interruption is also expected to impact revenues and profits for the fourth quarter of fiscal 2020.
— CDMO shares plummeted more than 15% during the after-hours.
Most Popular
ULTA Earnings: Highlights of Ulta Beauty’s Q4 2024 results
Ulta Beauty, Inc. (NASDAQ: ULTA), a leading retailer of cosmetics and personal care products, on Thursday reported a decrease in net sales for the fourth quarter of 2024. Fourth-quarter net
Key takeaways from Dollar General’s (DG) Q4 2024 earnings report
Shares of Dollar General Corporation (NYSE: DG) gained 5% on Thursday, following the company’s release of its fourth quarter 2024 earnings results. The discount store delivered a mixed performance for
DG Earnings: All you need to know about Dollar General’s Q4 2024 earnings results
Dollar General Corporation (NYSE: DG) reported its fourth quarter 2024 earnings results today. Net sales increased 4.5% year-over-year to $10.3 billion. Same-store sales increased 1.2%. Net income of $191.2 million was
Comments
Comments are closed.